Dr. David Puett

Q: What Schools Are Affiliated With Dr. David Puett

Dr. David Puett is affiliated with the following schools: Vanderbilt University, University of Georgia

Dr. David Puett's AcademicInfluence.com Rankings

Dr. David Puett

Engineering

#5456

World Rank

#6715

Historical Rank

Biomedical Engineering

#416

World Rank

#425

Historical Rank

engineering Degrees

Dr. David Puett

Philosophy

#7568

World Rank

#10802

Historical Rank

Logic

#4618

World Rank

#5933

Historical Rank

philosophy Degrees

Download Badge

Engineering
Philosophy

Dr. David Puett's Degrees

Doctorate Medicine Harvard University

Why Is Dr. David Puett Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Dr. David Puett's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: importance of the endothelium and the no-reflow phenomenon. (1987) (425)
Published Trials of Nonmedicinal and Noninvasive Therapies for Hip and Knee Osteoarthritis (1994) (258)
Identification of a point mutation in the thyrotropin receptor of the hyt/hyt hypothyroid mouse. (1994) (207)
Endothelial and myocardial injury during ischemia and reperfusion: pathogenesis and therapeutic implications. (1989) (205)
Racial differences in plasma endothelin-1 concentrations in individuals with essential hypertension. (1996) (197)
An integrated transcriptomic and computational analysis for biomarker identification in gastric cancer (2010) (180)
Mechanisms and therapy of myocardial reperfusion injury. (1990) (155)
The equilibrium unfolding parameters of horse and sperm whale myoglobin. Effects of guanidine hydrochloride, urea, and acid. (1973) (155)
Degradation of receptor-bound human choriogonadotropin by murine Leydig tumor cells. (1978) (146)
The extracellular domain suppresses constitutive activity of the transmembrane domain of the human TSH receptor: implications for hormone-receptor interaction and antagonist design. (2000) (146)
Glutathione redox pathway and reperfusion injury. Effect of N-acetylcysteine on infarct size and ventricular function. (1988) (130)
Gonadotropin binding and stimulation of steroidogenesis in Leydig tumor cells. (1978) (129)
Determination of residues important in hormone binding to the extracellular domain of the luteinizing hormone/chorionic gonadotropin receptor by site-directed mutagenesis and modeling. (1996) (114)
Performance of elastography for the evaluation of thyroid nodules: a prospective study. (2013) (103)
Endothelin-1 promotes mitogenesis in airway smooth muscle cells. (1994) (100)
Oxypurinol limits myocardial stunning but does not reduce infarct size after reperfusion. (1987) (92)
Gender differences in the expression of endothelin receptors in human saphenous veins in vitro. (1998) (89)
Growth hormone conformation and conformational equilibria. (1974) (83)
Inhibition of the degradation of receptor-bound human choriogonadotropin by lysosomotropic agents, protease inhibitors, and metabolic inhibitors. (1978) (80)
Conformation and unfolding thermodynamics of epidermal growth factor and derivatives. (1976) (78)
Changes in the circular dichroic spectrum of colchicine associated with its binding to tubulin. (1981) (76)
Binding to tubulin of the colchicine analog 2-methoxy-5-(2', 3', 4'-trimethoxyphenyl)tropone. Thermodynamic and kinetic aspects. (1984) (74)
Association of Hashimoto's thyroiditis with thyroid cancer (2014) (74)
The carboxy-terminal region of the glycoprotein hormone alpha-subunit: contributions to receptor binding and signaling in human chorionic gonadotropin. (1992) (73)
A functional transmembrane complex: The luteinizing hormone receptor with bound ligand and G protein (2007) (70)
Potentiometric titrations and the helix–coil transition of poly(L‐glutamic acid) and poly‐L‐lysine in aqueous salt solutions (1968) (68)
A Model for Constitutive Lutropin Receptor Activation Based on Molecular Simulation and Engineered Mutations in Transmembrane Helices 6 and 7* (2002) (67)
Functional expression of yoked human chorionic gonadotropin in baculovirus-infected insect cells. (1995) (65)
Preservation of endothelial cell structure and function by intracoronary perfluorochemical in a canine preparation of reperfusion. (1987) (60)
The dynamics of the steroidogenic response of perifused Leydig tumor cells to human chorionic gonadotropin, ovine luteinizing hormone, cholera toxin, and adenosine 3',5'-cyclic monophosphate. (1981) (60)
On the conformation of the acetylcholine receptor protein from Torpedo nobiliana (1974) (58)
A study on the conformation and conformational stability of ribonuclease A and its peptic derivative, des-(121-124)-ribonuclease. (1972) (57)
Thyroid Nodules and Shear Wave Elastography: A New Tool in Thyroid Cancer Detection. (2015) (56)
Somatostatin conformation: evidence for a stable intramolecular structure from circular dichroism, diffusion, and sedimentation equilibrium. (1976) (56)
Contribution of subunits to the function of luteinizing hormone/human chorionic gonadotropin recombinants. (1981) (54)
Conserved amino acids participate in the structure networks deputed to intramolecular communication in the lutropin receptor (2011) (53)
Conformational studies on somatostatin and analogues. (1977) (52)
The role of pH, temperature, salt type, and salt concentration on the stability of the crystalline, helical, and randomly coiled forms of collagen. (1967) (51)
Genetic engineering of single-chain gonadotropins and hormone-receptor fusion proteins. (2000) (50)
The endothelin subtype A receptor undergoes agonist- and antagonist-mediated internalization in the absence of signaling. (1998) (50)
Demonstration by covalent cross-linking of a specific interaction between beta-endorphin and calmodulin. (1983) (49)
The regulation of granulosa cell proopiomelanocortin messenger ribonucleic acid by androgens and gonadotropins. (1986) (49)
Computational prediction of human proteins that can be secreted into the bloodstream (2008) (48)
Collagen-mediated platelet aggregation. Effects of collagen modification involving the protein and carbohydrate moieties. (1973) (48)
Intracellular uptake and catabolism of lutropin by testicular tissue in vivo (1977) (48)
Gonadotropin and subunit conformation. (1975) (45)
Role of the invariant aspartic acid 99 of human choriogonadotropin beta in receptor binding and biological activity. (1991) (45)
Delineation via site-directed mutagenesis of the carboxyl-terminal region of human choriogonadotropin beta required for subunit assembly and biological activity. (1991) (44)
Conformational studies on a glycosylated bovine pancreatic ribonuclease. (1973) (44)
A region in the human glycoprotein hormone alpha-subunit important in holoprotein formation and receptor binding. (1994) (43)
Beneficial long-term effect of intracoronary perfluorochemical on infarct size and ventricular function in a canine reperfusion model. (1987) (43)
Characterization of a region of the lutropin receptor extracellular domain near transmembrane helix 1 that is important in ligand-mediated signaling. (1999) (42)
Shear Wave Elastography and Cervical Lymph Nodes: Predicting Malignancy. (2016) (41)
The kinetic and equilibrium parameters of subunit association and gonadotropin dissociation. (1982) (41)
Protein Engineering of a Novel Constitutively Active Hormone-Receptor Complex* (1996) (40)
Differential trace labeling of calmodulin: investigation of binding sites and conformational states by individual lysine reactivities. Effects of beta-endorphin, trifluoperazine, and ethylene glycol bis(beta-aminoethyl ether)-N,N,N',N'-tetraacetic acid. (1985) (39)
DTA and heals of hydration of some polypeptides (1967) (38)
Gonadal defects and hormonal alterations in transgenic mice expressing a single chain human chorionic gonadotropin-lutropin receptor complex. (2005) (38)
Determination of hyperglycosylated human chorionic gonadotropin produced by malignant gestational trophoblastic neoplasias and male germ cell tumors using a lectin-based immunoassay and surface plasmon resonance (2007) (37)
The binding of isocolchicine to tubulin. Mechanisms of ligand association with tubulin. (1989) (37)
Interaction between proteins and salt solutions. II. Elasticity of collagen tendons (1965) (37)
Site-Directed Mutagenesis of the Human Chorionic Gonadotropin β-Subunit: Bioactivity of a Heterologous Hormone, Bovine α-Human des-(122–145)β (1989) (37)
Identification of Two Amino Acid Residues on the Extracellular Domain of the Lutropin/Choriogonadotropin Receptor Important in Signaling (*) (1995) (36)
The luteinizing hormone receptor: Insights into structure–function relationships and hormone-receptor-mediated changes in gene expression in ovarian cancer cells (2010) (36)
Amino/carboxyl-terminal deletion mutants of human choriogonadotropin beta. (1993) (36)
The metabolism of luteinizing hormone. plasma clearance, urinary excretion, and tissue uptake (1975) (35)
Glycoprotein hormones : structure, function, and clinical implications (1994) (35)
The application of chemical studies of human chorionic gonadotropin to visualize its three-dimensional structure. (1993) (35)
Endothelin-1 promotes steroidogenesis and stimulates protooncogene expression in transformed murine Leydig cells. (1993) (34)
Adrenocorticotropic hormone biotransformation, clearance, and catabolism. (1978) (34)
hCG-receptor binding and transmembrane signaling (1996) (34)
Thromboxane synthetase inhibitor UK38,485 lowers blood pressure in the adult spontaneously hypertensive rat. (1984) (34)
Distribution of endothelin receptors in saphenous veins of African Americans: implications of racial differences. (1999) (34)
A Comparative Analysis of Gene-Expression Data of Multiple Cancer Types (2010) (33)
Identification of beta-endorphin residues 14-25 as a region involved in the inhibition of calmodulin-stimulated phosphodiesterase activity. (1983) (32)
Yoked complexes of human choriogonadotropin and the lutropin receptor: evidence that monomeric individual subunits are inactive. (2002) (32)
Interaction between proteins and salt solutions. III. Effect of salt type and concentration on the shrinkage temperature (1965) (32)
Human Chorionic Gonadotropin α-Subunit from Cultured Choriocarcinoma (JEG) Cells: Comparison of the Subunit Secreted Free with That Prepared from Secreted Human Chorionic Gonadotropin (1979) (31)
Alpha-subunit conformation in glycoprotein hormones and recombinants as assessed by specific antisera. (1982) (31)
Tetanus toxin. The effect of chemical modifications on toxicity, immunogenicity, and conformation. (1975) (31)
Contributions of arginines-43 and -94 of human choriogonadotropin beta to receptor binding and activation as determined by oligonucleotide-based mutagenesis. (1991) (31)
Circular dichroism of mitochondrial membranes before and after extraction of lipids and surface proteins. (1972) (30)
Identification of amino acid residues in transmembrane helices VI and VII of the lutropin/choriogonadotropin receptor involved in signaling. (1996) (30)
Mutagenesis of the ‘determinant loop’ region of human choriogonadotropin β (1993) (29)
Site-directed mutagenesis of amino acids 33-44 of the common alpha-subunit reveals different structural requirements for heterodimer expression among the glycoprotein hormones and suggests that cyclic adenosine 3',5'-monophosphate production and growth promotion are potentially dissociable functions (1996) (29)
A comparison of the conformational stabilities of homologous hemoproteins. Myoglobin from several species, human hemoglobin and subunits. (1973) (29)
The Gonadotropin Hormones and Their Receptors (2009) (29)
A Computational Method for Prediction of Excretory Proteins and Application to Identification of Gastric Cancer Markers in Urine (2011) (29)
Cyclic nucleotide phosphodiesterase activity in 10-nm filaments and microtubule preparations from bovine brain. (1979) (28)
Heterogeneity of the human chorionic gonadotropin alpha-subunit secreted by cultured choriocarcinoma (JEG) cells. (1979) (28)
Structure‐Function Relationships of the Luteinizing Hormone Receptor (2005) (28)
Conformational stability and self-association of zinc-free bovine insulin at neutral pH. (1977) (28)
Transiently elevated levels of c-fos and c-myc oncogene messenger ribonucleic acids in cultured murine Leydig tumor cells after addition of human chorionic gonadotropin. (1989) (28)
Regulation of gene expression in ovarian cancer cells by luteinizing hormone receptor expression and activation (2011) (28)
Immunoreactive endothelin-1 concentrations in follicular fluid of women with and without endometriosis undergoing in vitro fertilization-embryo transfer. (1994) (27)
MicroRNA Expression and Regulation in Human Ovarian Carcinoma Cells by Luteinizing Hormone (2011) (27)
Steroidogenesis in HCG-responsive Leydig cell tumor variants. (1979) (27)
Circular dichroism of corticotropin, fragment 1–24, and model compounds. An assessment of the contributions of the peptide chromophore and aromatic residues (1976) (26)
Functional properties of covalent beta-endorphin peptide/calmodulin complexes. Chlorpromazine binding and phosphodiesterase activation. (1985) (26)
Structural and Functional Studies of the Tryptic Core of the Human Chorionic Gonadotropin β-Subunit (1987) (26)
Interaction between proteins and salt solutions. IV. Enrichment of salts in collagen during denaturation (1967) (26)
Tryptic digestion of the alpha subunit of human choriogonadotropin. (1986) (26)
Tritium labeling of luteinizing hormone by reductive methylation. (1974) (25)
Ovarian contents of immunoreactive β-endorphin and α-N-acetylated opioid peptides in rats (1991) (25)
Detection of chloramphenicol acetyl transferase activity in transfected cells: a rapid and sensitive HPLC-based method. (1985) (25)
Functional role of transmembrane helix 7 in the activation of the heptahelical lutropin receptor. (2000) (25)
Helix formation of poly-L-lysine thiocyanate in aqueous solutions. (1967) (25)
Specificity of cognate ligand-receptor interactions: fusion proteins of human chorionic gonadotropin and the heptahelical receptors for human luteinizing hormone, thyroid-stimulating hormone, and follicle-stimulating hormone. (2003) (24)
Hydrodynamic properties of D-beta-hydroxybutyrate dehydrogenase, a lipid-requiring enzyme. (1978) (24)
Shear wave elastography and parathyroid adenoma: A new tool for diagnosing parathyroid adenomas. (2016) (23)
Characterization of protein tyrosine kinase activity in murine Leydig tumor cells. (1986) (23)
Specific acylation of calmodulin. Synthesis and adduct formation with a fluorenyl-based spin label. (1984) (23)
Contributions of intracellular loops 2 and 3 of the lutropin receptor in Gs coupling. (2008) (23)
The Maya ICBG: Drug Discovery, Medical Ethnobiology, And Alternative Forms Of Economic Development In The Highland Maya Region Of Chiapas, Mexico (1999) (23)
Arthritis after bacillus Calmette-Guerin therapy. (1992) (23)
beta-Endorphin and deletion peptides. A correlation of opiate receptor affinity with helix potential. (1982) (23)
Immunocytochemical localization and enzymatic distribution of rat ovarian aromatase. (1991) (23)
Effects of the binding of myosin light chain kinase on the reactivities of calmodulin lysines. (1986) (22)
Binding of amphiphilic peptides to a carboxy-terminal tryptic fragment of calmodulin. (1988) (22)
Inhibition of Cytochrome P-450 Aromatase Activity by Plant Extracts (1990) (21)
Lectin immunoassays using antibody fragments to detect glycoforms of human chorionic gonadotropin secreted by choriocarcinoma cells. (2005) (21)
Conformational changes induced in human alpha 2-macroglobulin by protease and nucleophilic modification. (1983) (20)
Interaction between proteins and salt solutions. I. Thermodynamic parameters of dilution for gelatin and collagen (1965) (20)
Calcium effects on calmodulin lysine reactivities. (1987) (20)
Glycoprotein Hormones (1994) (20)
N-terminal amino acid sequence of the -subunit of human pituitary luteinizing hormone. (1972) (20)
Inhibition of aromatase activity and of endocrine-responsive tumor growth by 10-propargylestr-4-ene-3, 17-dione and its 17-propionate derivative (1987) (19)
Conformational and molecular weight studies of tetanus toxin and its major peptides. (1982) (19)
Lysine residues 2 and 104 of the human chorionic gonadotrophin beta subunit influence receptor binding. (1993) (19)
The effect of regulation of high blood pressure on plasma endothelin-1 levels in blacks with hypertension. (1998) (19)
Identification of ionizable amino acid residues on the extracellular domain of the lutropin receptor involved in ligand binding. (1999) (18)
Evidence for structural dissociation of two biologic actions of growth hormone. (1975) (18)
Rapid exacerbation of scleroderma in a patient treated with interleukin 2 and lymphokine activated killer cells for renal cell carcinoma. (1994) (18)
Binding of trifluoperazine and fluorene-containing compounds to calmodulin and adducts. (1986) (18)
Identification of conserved amino acid residues in the beta subunit of human choriogonadotropin important in holoprotein formation. (1994) (18)
Renal and hepatic lysosomal catabolism of luteinizing hormone (1976) (18)
Lutropin Receptor Function: Insights from Natural, Engineered, and Computer‐Simulated Mutations (2001) (18)
Chain folding in ribonuclease A derivatives lacking five and six carboxyl-terminal residues. (1972) (18)
Divergence between ovarian aromatase activity, estrogen, and androgen levels in the cycling rat. (1990) (18)
Presence of aromatase inhibitors in cycads. (1995) (17)
Stress‐Optical Behavior of Rubber Networks at Large Deformations (1966) (17)
Circular dichroism of human pituitary luteinizing hormone and its glycopeptides. Curve resolution and band assignments to the peptide chromophore, aromatic residues, disulfides, and N-acetylated amino sugars. (2009) (17)
Shear wave elastography and Afirma™ gene expression classifier in thyroid nodules with indeterminate cytology: a comparison study (2018) (17)
Kinetics of collagen fold formation in human type I procollagen and the effect of disulfide bonds. (1981) (17)
Evidence for an important functional role of intracellular loop II of the lutropin receptor (1997) (17)
Characterization of the human chorionic gonadotrophin fractions in pregnancy urine. (1978) (17)
The tie that binds: design of biologically active single-chain human chorionic gonadotropins and a gonadotropin-receptor complex using protein engineering. (1998) (16)
Circular dichroic and immunological properties of human choriogonadotropin- beta carboxyl terminal peptides. (2009) (16)
Evidence for the synthesis of multiple pro-opiomelanocortin-like precursors in murine Leydig tumor cells. (1984) (15)
The Effect of Aqueous Salt Solutions on the Melting of Collagen and the Viscosity of Gelatin (1968) (15)
Lipid composition and gonadotropin-mediated lipid metabolism of the M5480 murine Leydig cell tumor. (1980) (15)
Quantitative evaluation of muscle weakness in scleroderma patients using magnetic resonance imaging and spectroscopy. (1993) (15)
Morphological and conformational studies of Tamm-Horsfall urinary glycoprotein (1973) (15)
Phosphorus-31 nuclear magnetic resonance analysis of epidermal growth factor action in A-431 human epidermoid carcinoma cells and SV-40 virus transformed mouse fibroblasts. (1983) (15)
Expression of functional lutropin/choriogonadotropin receptor in the baculovirus system (1996) (15)
Identification of Ionizable Amino Acid Residues on the Extracellular Domain of the Lutropin Receptor Involved in Ligand Binding1. (1999) (15)
A single amino acid residue replacement in the beta subunit of human chorionic gonadotrophin results in the loss of biological activity. (1992) (15)
Conformational studies on concentrated solutions of poly(γ‐benzyl L‐glutamate) (1971) (15)
Elasticity of Semicrystalline Polymers1 (1965) (15)
Circular dichroism of gonadotropin recombinants. (2009) (14)
Evidence for renotropic activity in ovine pituitaries. (1979) (14)
SPIN LABELED CALMODULIN: A NEW PROBE FOR STUDYING Ca2+ AND MACROMOLECULAR INTERACTIONS * (1980) (14)
Effects of interaction with calcineurin on the reactivities of calmodulin lysines. (1988) (14)
Characterization of endothelin receptor subtypes on airway smooth muscle cells. (1995) (13)
Network behavior of polyurethane elastomers (1967) (13)
A biologically active single chain human chorionic gonadotropin analog with altered receptor binding properties. (2000) (13)
Homodimer formation by the individual subunits of bovine lutropin as determined by sedimentation equilibrium. (1997) (13)
Replacement of the invariant tyrosine in the CAGY region of the human chorionic gonadotropin β subunit (1993) (13)
Inhibition of Leydig tumor cell steroidogenesis by 10-propargylestr-4-ene-3,17-dione, an irreversible aromatase inhibitor. (1985) (12)
Luteinizing Hormone–Induced Up-Regulation of ErbB-2 Is Insufficient Stimulant of Growth and Invasion in Ovarian Cancer Cells (2008) (12)
Delineation of Subunit and Receptor Contact Sites by Site-Directed Mutagenesis of hCGβ (1994) (12)
Functional Differences of Invariant and Highly Conserved Residues in the Extracellular Domain of the Glycoprotein Hormone Receptors* (2010) (12)
Binding of vanadium (IV) to the phosphatase calcineurin (1995) (12)
Induction of an estrogen-dependent early steroidogenic lesion in murine Leydig tumor cells. (1985) (12)
des-(1–13) Human β-endorphin interacts with calmodulin (1983) (11)
Endothelin degradation by vascular smooth muscle cells (1996) (11)
Biotransformations of pituitary luteinizing hormone in serum and urine. I. Association with serum components. (1976) (11)
Circular Dichroic Spectroscopy of N-Acetylglucosaminyltransferase V and Its Substrate Interactions* (1997) (11)
Structural aspects of luteinizing hormone receptor (2002) (11)
Conformational and metabolic aspects of gonadotropins. (1974) (11)
Consequences of Single-Chain Translation on the Structures of Two Chorionic Gonadotropin Yoked Analogs in α-β and β-α Configurations (2003) (10)
Effects of human choriogonadotropin on mitochondrial and microsomal cytochrome P-450 levels in mouse testes. (1983) (10)
High-level expression of a functional single-chain human chorionic gonadotropin-luteinizing hormone receptor ectodomain complex in insect cells. (2001) (10)
Interaction of tritiated β-endorphin with rat brain membranes (1981) (10)
A label selection approach to assess the role of individual amino groups in human choriogonadotropin receptor binding. (1994) (10)
Role of Neutral Salts on the Denaturation Temperature of Biopolymers (1966) (9)
Metabolism of endothelin-1 by neuroblastoma×glioma hybrid (NG108–15) cells (1997) (9)
Partial purification and characterization of a renotropic fraction from ovine pituitaries. (1982) (9)
Fluorescent adducts of wheat calmodulin implicate the amino-terminal region in the activation of skeletal muscle myosin light chain kinase. (1990) (9)
Epidermal growth factor modulates intracellular arachidonic acid levels in MA-10 cultured Leydig tumor cells (1991) (9)
Biotransformations of pituitary luteinizing hormone in serum and urine. II. Evidence for reduced potency following urinary excretion. (1976) (9)
Phenothiazine binding by a homolog of calpactin, the pp60src tyrosine kinase substrate (1987) (9)
Thermoelasticity and the Temperature Coefficient of Unperturbed Polymer Dimensions (1967) (8)
Extragonadal effects of luteinizing hormone in mice. (1989) (8)
A Biologically Active Single Chain Human Chorionic Gonadotropin Analog with Altered Receptor Binding Properties1. (2000) (8)
Identification of conventional and novel endothelin receptors in sheep choroid plexus cells (1996) (8)
Identification of receptor binding and activation sites in endothelin-1 by use of site-directed mutagenesis. (1995) (8)
Tissue-specific stimulation of ornithine decarboxylase activity by pituitary factors immunologically related to growth hormone. (1977) (8)
Structural analysis of yoked chorionic gonadotropin-luteinizing hormone receptor ectodomain complexes by circular dichroic spectroscopy. (2003) (8)
Extragonadal effects of luteinizing hormone in mice. (1989) (8)
Characterization of the desensitized state of Leydig tumor cells. (1981) (8)
The extreme C-terminal region of Gαs differentially couples to the luteinizing hormone and beta2-adrenergic receptors. (2011) (8)
The effects of denaturant and temperature on the circular dichroic spectrum of ovine lutropin-alpha. (2009) (7)
Comparison of steroidogenic potencies of homologous and heterologous gonadotropins in rat and mouse Leydig cells (1991) (7)
Circular dichroism of glycopeptide fractions from alpha1-acid glycoprotein, thyroglobulin, and ovalbumin. (1977) (7)
On the formation of secondary and tertiary structure in apomyoglobin. (1972) (7)
On the role of the invariant glutamine at position 54 in the human choriogonadotropin β subunit (1994) (7)
The luteinizing hormone receptor: influence of buffer composition on ligand binding and signaling of wild type and mutant receptors (2003) (7)
Characterization of pregnant mare's serum gonadotropin-stimulated rat ovarian aromatase and its inhibition by 10-propargylestr-4-ene-3,17-dione. (1988) (7)
Electron spin resonance of calmodulin-vanadyl complexes. (1987) (7)
Preparation of tritium labeled beta-endorphin suitable for studying brain receptor interactions. (1981) (7)
Effects of hormones and intracellular mediators on differentiated functions of cultured Leydig tumor cells (1989) (7)
Haemoglobin Vanderbilt (α2β289Ser→Arg): a New Haemoglobin with High Oxygen Affinity and Compensatory Erythrocytosis (1978) (7)
Tyrosine protein kinase activity in purified rat Leydig cells. (1983) (7)
Endothelin binding to NG108-15 cells: evidence for conventional ETA and ETB receptor subtypes and super-high affinity binding components. (1996) (6)
CHAPTER 2 – The Gonadotropin Hormones and Their Receptors (2009) (6)
Differential responses of an invariant region in the ectodomain of three glycoprotein hormone receptors to mutagenesis and assay conditions (2002) (6)
Human α-subunit analogs act as partial agonists to the thyroid-stimulating hormone receptor (2004) (5)
Trp-21 is important in the processing and secretion of big endothelin-1 (1995) (5)
Elasticity of Block Copolymers (1964) (5)
Binding of a synthetic beta-endorphin peptide to calmodulin. (1985) (5)
Epidermal growth factor and cyclic AMP stimulation of distinct protein kinase activities in Leydig cell tumor membranes. (1982) (5)
Contribution of the amino terminal tyrosine to the interaction of γ-endorphin with opiate receptors (1982) (5)
Cancer Bioinformatics (2014) (5)
Identification of endothelin receptor subtypes in sheep choroid plexus (1997) (5)
A Possible Effect of Concentrated Oolong Tea Causing Transient Ischemic Attack-Like Symptoms (2013) (5)
An enzymatically active cross-linked complex of calmodulin and rabbit skeletal muscle myosin light chain kinase. (1989) (4)
Divergent effects of phenothiazines on Leydig tumor cell steroidogenesis and adenylate cyclase activity. (1983) (4)
Designer Gonadotropins and Receptors: The Prospect of Recombinant Technology (2000) (4)
Structural and functional studies of the tryptic core of the human chorionic gonadotropin beta-subunit. (1987) (4)
Determining the affinity of hormone-receptor interaction. (2009) (4)
Holoprotein formation of human chorionic gonadotropin: differential trace labeling with acetic anhydride. (1994) (4)
Tetanus toxin conformation (1974) (4)
Single-chain human chorionic gonadotropin analogs containing the determinant loop of the beta-subunit linked to the alpha-subunit. (2003) (4)
Pseudo-phase diagrams of poly-L-lysine and poly(L-glutamic acid) in aqueous salt solutions. (1968) (4)
Aromatase and aromatase inhibitors: from enzymology to selective chemotherapy. (1988) (4)
Erratum: Racial differences in plasma endothelin-1 concentrations in individuals with essential hypertension (Hypertension (October 1996) 28 (652-655)) (1997) (4)
Glutathione Redox Pathway and Reperfusion Injury (2005) (4)
Comparative conformational analysis of human choriomammotropin and somatotropin from several species. (2009) (3)
Testicular membranes with improved stability of the gonadotropin receptor. (1982) (3)
Characterization of specific fluorenylmethyloxycarbonyl-containing calmodulin adducts by spectroscopy and phosphodiesterase stimulation (1987) (3)
Electron Paramagnetic Resonance Spectroscopy of Nitroxide-Labeled Calmodulin (2014) (3)
Fusion proteins of human gonadotropins and gonadotropin-receptor complexes (2002) (3)
Cytoskeletal Regulation of hCG-Induced Receptor Clustering in Transformed Leydig Cells (1995) (3)
Effect of 4-hydroxyandrostenedione on murine Leydig tumor cell steroidogenesis. (1991) (3)
Circular dichroism of human urinary Tamm-Horsfall glycoprotein (1977) (2)
BIOLOGY OF AGING: IDENTIFIED DRIVERS AND INTERVENTIONS FOR OPTIMAL HEALTHSPAN (2018) (2)
Molecular modeling of transmembrane helices 6 and 7 of the heptahelical lutropin receptor. (2002) (2)
Interaction of α-N-acetyl-β-endorphin and calmodulin (1988) (2)
Inhibition of growth and appearance of estrogen-dependent rat mammary tumors by 10-propargylestr-4-ene-3,17-dione, an aromatase inhibitor (2004) (2)
Demonstration of distinct forms of testicular adenylate cyclases associated with germinal and Leydig cell fractions. (1982) (2)
Bone morphogenetic protein-4 affects both trophoblast and non-trophoblast lineage-associated gene expression in human embryonic stem cells (2012) (2)
Steroidogenesis and early response gene expression in MA-10 Leydig tumor cells following heterologous receptor down-regulation and cellular desensitization (2016) (2)
Renal coagulopathy, thrombocytopenia, and the anticardiolipin antibody: therapeutic response to corticosteroids and aspirin but not anticoagulation. (1994) (2)
Hormonal induction of specific protein synthesis in murine Leydig tumor cells. (1985) (2)
The endocrine module: An integrated course for first‐year medical students combining lecture‐based and modified problem‐based curricula (1991) (2)
Consequences of single-chain translation on the structures of two chorionic gonadotropin yoked analogs in alpha-beta and beta-alpha configurations. (2003) (2)
Site-directed mutagenesis of the human chorionic gonadotropin beta-subunit: bioactivity of a heterologous hormone, bovine alpha-human des-(122-145)beta. (1989) (2)
Single-chain human chorionic gonadotropin analogs containing the determinant loop of the -subunit linked to the -subunit (2003) (2)
The Eguilibrium Unfolding Parameters of Horse and Sperm Whale Myoglobin (2003) (1)
Changes in alpha 2-macroglobulin conformation by reaction with trypsin and methylamine. (1983) (1)
Understanding Cancer Invasion and Metastasis (2014) (1)
Mutations of Arg68 of the human chorionic gonadotrophin beta subunit lead to reduced secretion. (1996) (1)
Cancer Classification and Molecular Signature Identification (2014) (1)
Luteinizing Hormone Receptor Signaling (2003) (1)
Haemoglobin Vanderbilt (alpha2beta289Ser leads to Arg): a new haemoglobin with high oxygen affinity and compensatory erythrocytosis. (1978) (1)
Effect of luteinizing hormone releasing hormone (LHRH) agonists on body weight in rats (1988) (1)
Tribute to a pioneer in the glycoprotein hormone field, Dr. John G. Pierce (2010) (1)
Ovarian contents of immunoreactive beta-endorphin and alpha-N-acetylated opioid peptides in rats. (1991) (1)
Circular dichroic spectroscopy of Arg46-nicked ovine lutropin α and derived fragments (1996) (1)
CHANGES IN α2‐MACROGLOBULIN CONFORMATION BY REACTION WITH TRYPSIN AND METHYLAMINE a (1983) (1)
Tightly regulated and inducible expression of a yoked hormone-receptor complex in HEK 293 cells. (2004) (1)
Ontogeny and stimulation of rat ovarian aromatase [Poster 36] (1987) (1)
Human alpha-subunit analogs act as partial agonists to the thyroid-stimulating hormone receptor: differential effects of free and yoked subunits. (2004) (1)
Omic Data, Information Derivable and Computational Needs (2014) (1)
Renal uptake of lutropin. Studies based on electron microscopic autoradiography and nephrectomy (1977) (1)
Surface retention of an inactivating lutropin receptor mutant in exoloop 3 (1998) (1)
Determination of the binding of tetraalkylammonium bromides to gelatin by an ultracentrifuge method. (1968) (1)
Enzymatic fragmentation of tetanus toxin. Identification and characterization of an atoxic, immunogenic fragment (1978) (1)
Preparation and characterization of a novel group of pituitary-derived peptides stimulatory for DNA synthesis in fibroblasts. (1980) (1)
Vanadyl binding to a testicular S-100-like protein and to calmodulin: Electron paramagnetic resonance spectra of VO2+-protein complexes (1987) (1)
des-(1-13) human beta-endorphin interacts with calmodulin. (1983) (0)
How I became a biochemist (2005) (0)
Cell Proliferation from Regulated to Deregulated States Via Epigenomic Responses (2014) (0)
with Murine Leydig Cell Tumor Proteins Estrogen-induced Protein in MCF-7 Human Breast Cancer Cells Cross-Reactivity of a Monoclonal Antibody Directed against an Updated (2006) (0)
Transcriptomic Analysis of Human Ovarian Cancer Cells: Changes Mediated by Luteinizing Hormone Receptor Activation (2012) (0)
The carbohydrate moiety of human chorionic gonadotropin: lack of competition with HCG for testicular receptors and anti-HCG-serum. (1979) (0)
Understanding Cancer at the Genomic Level (2014) (0)
A transformed murine Leydig cell line expresses the ETA receptor subtype (1994) (0)
Overview of Gonadotropins (1980) (0)
Human chorionic gonadotropin alpha-subunit from cultured choriocarcinoma (JEG) cells: comparison of the subunit secreted free with that prepared from secreted human chorionic gonadotropin. (1979) (0)
Cancer Development in Competitive and Hostile Environments (2014) (0)
Multiple Routes for Survival: Understanding How Cancer Evades Apoptosis (2014) (0)
Cross-reactivity of a monoclonal antibody directed against an estrogen-induced protein in MCF-7 human breast cancer cells with murine Leydig cell tumor proteins. (1986) (0)
- N-acetylatedopioid peptides in rats (2008) (0)
Hyaluronic Acid: A Key Facilitator of Cancer Evolution (2014) (0)
Conformational studies on concentrated solutions of poly(gamma-benzyl L-glutamate). (1971) (0)
Vanadium (IV) inhibits calmodulin-stimulated skeletal muscle myosin light chain kinase activity. (1995) (0)
Testicular, Kinase Activity: High Levels in Purified Leydig Cells (1984) (0)
Basic Cancer Biology (2014) (0)
Hormones, cell biology, and cancer. Perspectives and potentials. Proceedings of a satellite symposium of the 1986 American Society for Cell Biology meeting. Washington, DC, December 7, 1986. (1988) (0)
Single-chain human chorionic gonadotropin analogs containing the determinant loop of the (cid:1) -subunit linked to the (cid:2) -subunit (2003) (0)
Study of the control of pro-thyroid hormone (thyroglobulin) gene expression (1986) (0)
An endothelin-A/lutropin chimeric receptor exhibits ligand-mediated internalization in the absence of signaling (2002) (0)
Fusion proteins of human gona dotr opins and gonad otr opin-r eceptor complexes (2002) (0)
In Silico Investigation of Cancer Using Publicly Available Data (2014) (0)
Gonadotropin binding and stimulat in Leydig tumor cells (choriogonadotropin/hormone action/testicular tumor) (2016) (0)
Jan Hermans (1933‐2018): Red‐blooded biophysicists study hemoglobin (2019) (0)
MYOCARDIAL ISCHEMIA Preservation ofendothelial cell structure and function by intracoronary perfluorochemical in a canine preparation of reperfusion (2005) (0)
Interaction of tritiated beta-endorphin with rat brain membranes. (1981) (0)
Fluorescence spectroscopic studies of tyrosine environment and ligand binding of plant calmodulin (1990) (0)
Subject Index Vol. 5, 1995 (1995) (0)
Understanding Cancer as an Evolving Complex System: Our Perspective (2014) (0)
Limited Small Scale Field Study for Destruction of Organic Contaminants by Ultraviolent Ozone Oxidation. (1977) (0)
Microarray-based transcriptome profiling of ovarian cancer cells. (2013) (0)
Testicular tyrosine-specific protein kinase activity: high levels in purified Leydig cells. (1984) (0)
Elucidation of Cancer Drivers Through Comparative Omic Data Analyses (2014) (0)
Erratum: Stress‐Optical Behavior of Rubber Networks at Large Deformations (1966) (0)
In vitro bioactivity of human chorionic gonadotropin in the mare (1998) (0)
Circular dichroic spectroscopy of Arg46-nicked ovine lutropin alpha and derived fragments. (1996) (0)
Advances in gene technology : molecular biology of the endocrine system : proceedings of the Eighteenth Miami Winter Symposium, Miami, Florida, U.S.A., February 3-7, 1986 (1986) (0)
Stress Optical Behavior of Rubber Networks at Large Deformations (1966) (0)
Cancer After Metastasis: The Second Transformation (2014) (0)
Searching for Cancer Biomarkers in Human Body Fluids (2014) (0)
Applications of molecular biology to testicular function and regulation. (1984) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Dr. David Puett?

Dr. David Puett is affiliated with the following schools:

Dr. David Puett's Academic­Influence.com Rankings

Dr. David Puett's Degrees

Why Is Dr. David Puett Influential?

Dr. David Puett's Published Works

Published Works

What Schools Are Affiliated With Dr. David Puett?

Dr. David Puett's AcademicInfluence.com Rankings